BioHarvest Sciences (BHST) names Prof. Hezi Levy to board, David Tsur exits

Rhea-AI Filing Summary

BioHarvest Sciences Inc. filed a report describing changes to its board of directors. The company announced that David Tsur resigned as a director after serving since 2021. It simultaneously appointed Prof. Hezi Levy to the board, effective immediately.

The filing highlights Prof. Levy’s decades of leadership in Israel’s healthcare system. He is a physician who previously served as Director General of the Israeli Ministry of Health during the COVID-19 pandemic, Head of the Medical Corps of the Israel Defense Forces with the rank of Brigadier General, and General Manager of Barzilai Medical Center.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2026

Commission file number: 001-42389

BIOHARVEST SCIENCES INC.

(Exact name of Registrant as specified in its charter)

Not applicable

(Translation of Registrant’s name into English)

1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

☐ Form 20-F ☒ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

SUBMITTED HEREWITH

Exhibits:

Exhibit	Description
99.1	Material Change Report dated March 6, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BIOHARVEST SCIENCES INC.
	(Registrant)
Date: March 6, 2026	/s/ David Ryan
	Name: David Ryan
	Title: Vice-President, Investor Relations & Secretary

FORM 51-102F3

MATERIAL CHANGE REPORT

Item 1.Name and Address of Company 

BIOHARVEST SCIENCES INC.

Suite 1140 – 625 Howe Street

Vancouver, BC, V6C 2T6

(the “Company” or “BioHarvest”)

Item 2.Date of Material Change 

March 3, 2025.

Item 3.News Release 

The news release was issued on March 5, 2026 and disseminated by Newsfile Corp.

Item 4.Summary of Material Change 

The Company announced changes to it’s board of directors.

Item 5.Full Description of Material Change 

The Company announced the resignation of David Tsur as a director of the Company. Mr. Tsur served as a director since 2021. The Company also announced the immediate appointment of Prof. Hezi Levy to replace Mr. Tsur on its board of directors.

Prof. Levy joins the Board with decades of leadership experience across Israel’s healthcare system. A physician by education, Prof. Levy previously served as Director General of the Israeli Ministry of Health, including during the COVID-19 pandemic, where he played a central role in guiding national healthcare policy. Prof. Levy also served as Head of the Medical Corps of the Israel Defense Forces (IDF) with the rank of Brigadier General and was the General Manager of Barzilai Medical Center for many years, overseeing one of Israel’s major hospitals and complex healthcare operations.

Item 6.Reliance on Subsection 7.1(2) of National Instrument 51-102 

Not applicable.

Item 7.Omitted Information 

None.

Item 8.Executive Officer 

For further information, please contact:

David Ryan

Secretary and VP, Investor Relations

604 622-1187

Item 9.Date of Report 

March 6, 2026.

FAQ

What board changes did BioHarvest Sciences (BHST) report in this filing?

BioHarvest Sciences reported the resignation of director David Tsur and the immediate appointment of Prof. Hezi Levy to its board. The change was described as a material change and disclosed through a news release issued on March 5, 2026.

Who is Prof. Hezi Levy, the new director at BioHarvest Sciences (BHST)?

Prof. Hezi Levy is a physician with decades of leadership experience in Israel’s healthcare system. He previously served as Director General of the Israeli Ministry of Health, Head of the Israel Defense Forces Medical Corps, and General Manager of Barzilai Medical Center, overseeing major healthcare operations.

When did the board change at BioHarvest Sciences (BHST) occur?

The material change date is listed as March 3, 2025, with disclosure via a news release on March 5, 2026. The company states that Prof. Hezi Levy’s appointment to the board is effective immediately as he replaces resigning director David Tsur.

How long did outgoing director David Tsur serve on BioHarvest Sciences (BHST)’s board?

The filing states that David Tsur served as a director of BioHarvest Sciences since 2021. His resignation is treated as a material change, and the company has appointed Prof. Hezi Levy to replace him on the board of directors.

How did BioHarvest Sciences (BHST) disclose this board change to the market?

BioHarvest Sciences issued a news release on March 5, 2026, disseminated by Newsfile Corp, to announce the director resignation and new appointment. The same information is summarized in the material change report filed as part of this Form 6-K.

Who can investors contact at BioHarvest Sciences (BHST) for more information on the board change?

Investors are directed to contact David Ryan, Secretary and Vice-President, Investor Relations. The filing provides his telephone number, 604 622-1187, as the primary contact for further information regarding this reported material change.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 MATERIAL CHANGE REPORT DATED MARCH 6, 2026 7.1 KB